Search - tctmd.com

Displaying 321 - 340 of 869

Sort: Relevancy | Date

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

News Conference News ESC 2019

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

Michael O'Riordan

September 03, 2019

News Conference News ESC 2019

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Todd Neale

September 03, 2019

News Conference News ESC 2019

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Yael L. Maxwell

September 03, 2019

News Industry News

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

September 03, 2019

News Conference News ESC 2019

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

Shelley Wood

September 03, 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Published Cohort

News Conference News ESC 2019

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Yael L. Maxwell

September 03, 2019

News Conference News ESC 2019

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

Michael O'Riordan

September 02, 2019

PURE Sturdy: New insights into anthropometrics and cardiovascular outcomes in 142,000 adults from 21 countries followed for 9 years

Presentation ESC 2019

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

Presenter: Darryl P. Leong

September 02, 2019

News Conference News ESC 2019

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

Shelley Wood

September 02, 2019

News Conference News ESC 2019

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Yael L. Maxwell

September 02, 2019

News Conference News ESC 2019

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Conference News ESC 2019

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

Michael O'Riordan

September 01, 2019

News Conference News ESC 2019

HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin

Todd Neale

September 01, 2019

Presentation ESC 2019

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

Presenter: Deepak Bhatt

September 01, 2019

News Conference News ESC 2019

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Shelley Wood

September 01, 2019

News Conference News ESC 2019

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Michael O'Riordan

September 01, 2019

Advertisement

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Ruling Out MI Safe With 0/1-Hour High-Sensitivity Troponin: RAPID-TNT

For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior: ENTRUST-AF PCI

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

CLARIFY at 5 Years: Angina Predictive of MI/CV Death Only in Prior MI Patients

ORION-11: Inclisiran Shows Promise, Safety in Largest Cohort to Date

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

PURE Study: New Insights Into Anthropometrics and Cardiovascular Outcomes in 142,000 Adults From 21 Countries Followed For 9 Years

MITRA-FR at 2 Years: Still No Benefit of MitraClip Over Meds

BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests

Nonphysician, Community Intervention Curbs CV Risk Factors: HOPE 4

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Supplemental Oxygen Fails Once Again in ACS Patients: NZOTACS

HiSTORIC Trial Supports Single-Test Rule-Out of MI Using High-Sensitivity Troponin

THEMIS: Ticagrelor Added to Aspirin in Patients with Stable Coronary Disease and Diabetes

DAPA-HF Details: Dapagliflozin Slashes HF Outcomes, Even in Nondiabetics

Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content